JC virus detection and JC virus-specific immunity in natalizumab-treated Multiple Sclerosis patients

被引：0
作者：
Roberta Mancuso
Marina Saresella
Ambra Hernis
Ivana Marventano
Cristian Ricci
Simone Agostini
Marco Rovaris
Domenico Caputo
Mario Clerici
机构：
[1] ONLUS,Don C. Gnocchi Foundation
[2] University of Milan,Department of Physiopathology and Transplantation
来源：
Journal of Translational Medicine | / 10卷
关键词：
Cell mediated immunity; Natalizumab; MS;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Induction of systemic TNFα in Natalizumab-treated multiple sclerosis
    Khademi, M.
    Stol, D.
    Olsson, T.
    Wallstrom, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (03) : 309 - 312
  • [22] JC Virus-Specific Immune Responses in Human Immunodeficiency Virus Type 1 Patients with Progressive Multifocal Leukoencephalopathy
    Khanna, Nina
    Wolbers, Marcel
    Mueller, Nicolas J.
    Garzoni, Christian
    Du Pasquier, Renaud A.
    Fux, Christoph A.
    Vernazza, Pietro
    Bernasconi, Enos
    Viscidi, Raphael
    Battegay, Manuel
    Hirsch, Hans H.
    JOURNAL OF VIROLOGY, 2009, 83 (09) : 4404 - 4411
  • [23] Host cell virus entry mechanisms enhance anti-JCV-antibody switch in natalizumab-treated multiple sclerosis patients
    Anat Achiron
    Gadi Miron
    Rina Zilkha-Falb
    David Magalashvili
    Mark Dolev
    Yael Stern
    Michael Gurevich
    Journal of NeuroVirology, 2016, 22 : 736 - 746
  • [24] Comparative Effectiveness of Early Natalizumab Treatment in JC Virus-Negative Relapsing-Remitting Multiple Sclerosis
    Campbell, Jonathan D.
    McQueen, R. Brett
    Miravalle, Augusto
    Corboy, John R.
    Vollmer, Timothy L.
    Nair, Kavita
    AMERICAN JOURNAL OF MANAGED CARE, 2013, 19 (04) : 278 - 285
  • [25] Host cell virus entry mechanisms enhance anti-JCV-antibody switch in natalizumab-treated multiple sclerosis patients
    Achiron, Anat
    Miron, Gadi
    Zilkha-Falb, Rina
    Magalashvili, David
    Dolev, Mark
    Stern, Yael
    Gurevich, Michael
    JOURNAL OF NEUROVIROLOGY, 2016, 22 (06) : 736 - 746
  • [26] Safety, anxiety and natalizumab continuation in JC virus-seropositive MS patients
    van Rossum, Johannis A.
    Vennegoor, Anke
    Balk, Lisanne
    Uitdehaag, Bernard M.
    Polman, Chris H.
    Killestein, Joep
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (01) : 108 - 111
  • [27] Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA
    Iacobaeus, E.
    Ryschkewitsch, C.
    Gravell, M.
    Khademi, M.
    Wallstrom, E.
    Olsson, T.
    Brundin, L.
    Major, E. O.
    MULTIPLE SCLEROSIS JOURNAL, 2009, 15 (01) : 28 - 35
  • [28] Disease-modifying drugs for multiple sclerosis and JC virus expression
    Miller, Craig S.
    Houff, Sidney A.
    Hopper, Jason
    Danaher, Robert J.
    Gurwell, Julie A.
    Lin, Yushun
    Vega, Nubia
    Berger, Joseph R.
    JOURNAL OF NEUROVIROLOGY, 2012, 18 (05) : 411 - 415
  • [29] JCV detection in multiple sclerosis patients treated with natalizumab
    Sadiq, Saud A.
    Puccio, Lauren M.
    Brydon, Edward W. A.
    JOURNAL OF NEUROLOGY, 2010, 257 (06) : 954 - 958
  • [30] JCV detection in multiple sclerosis patients treated with natalizumab
    Saud A. Sadiq
    Lauren M. Puccio
    Edward W. A. Brydon
    Journal of Neurology, 2010, 257 : 954 - 958
12345